These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26757448)

  • 1. Investigational drugs for autonomic dysfunction in Parkinson's disease.
    Perez-Lloret S
    Expert Opin Investig Drugs; 2016; 25(3):259-62. PubMed ID: 26757448
    [No Abstract]   [Full Text] [Related]  

  • 2. Autonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
    Montastruc JL; Senard JM; Rascol O; Rascol A
    Adv Neurol; 1996; 69():377-81. PubMed ID: 8615154
    [No Abstract]   [Full Text] [Related]  

  • 3. Society for Neuroscience--38th Annual Meeting--Therapeutics for Parkinson's disease.
    Gotham S
    IDrugs; 2009 Jan; 12(1):10-1. PubMed ID: 19127496
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological therapy of Parkinson's disease: current options and new avenues.
    Simola N; Pinna A; Fenu S
    Recent Pat CNS Drug Discov; 2010 Nov; 5(3):221-38. PubMed ID: 20726838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of autonomic dysfunction in Parkinson's disease].
    Crespo-Burillo JA; Alarcia-Alejos R
    Rev Neurol; 2015 Apr; 60(8):355-64. PubMed ID: 25857860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of orthostatic hypotension in Parkinson's disease: from pathophysiology to management.
    Pathak A; Senard JM
    Expert Rev Cardiovasc Ther; 2004 May; 2(3):393-403. PubMed ID: 15151485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic rhythms and Parkinson's disease: a chronopharmacologic approach to considering fluctuations in function.
    Bruguerolle B; Simon N
    Clin Neuropharmacol; 2002; 25(4):194-201. PubMed ID: 12151906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging drugs for autonomic dysfunction in Parkinson's disease.
    Perez-Lloret S; Rey MV; Pavy-Le Traon A; Rascol O
    Expert Opin Emerg Drugs; 2013 Mar; 18(1):39-53. PubMed ID: 23373820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Disorders of autonomic regulation in Parkinson syndrome].
    Jost WH
    Fortschr Neurol Psychiatr; 1995 May; 63(5):194-205. PubMed ID: 7782020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-motor symptoms in Parkinson's disease.
    Park A; Stacy M
    J Neurol; 2009 Aug; 256 Suppl 3():293-8. PubMed ID: 19711119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs to treat autonomic dysfunction in Parkinson's disease.
    Mov Disord; 2002; 17 Suppl 4():S103-11. PubMed ID: 12211150
    [No Abstract]   [Full Text] [Related]  

  • 12. Managing autonomic dysfunction in Parkinson's disease: a review of emerging drugs.
    Kulshreshtha D; Ganguly J; Jog M
    Expert Opin Emerg Drugs; 2020 Mar; 25(1):37-47. PubMed ID: 32067502
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic Applications of Botulinum Neurotoxin for Autonomic Symptoms in Parkinson's Disease: An Updated Review.
    Mitchell SD; Sidiropoulos C
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33808714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autonomic disorders in idiopathic parkinsonism.
    Martignoni E; Micieli G; Cavallini A; Pacchetti C; Magri M; Nappi G
    J Neural Transm Suppl; 1986; 22():149-61. PubMed ID: 3465869
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment of non-motor symptoms in Parkinson's disease.
    Müller T
    Expert Opin Pharmacother; 2002 Apr; 3(4):381-8. PubMed ID: 11934340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Siagoside. GM1, Sygen.
    Drugs R D; 1999 Jan; 1(1):36-7. PubMed ID: 10565981
    [No Abstract]   [Full Text] [Related]  

  • 17. Autonomic dysfunction in Parkinson's disease.
    Dewey RB
    Neurol Clin; 2004 Oct; 22(3 Suppl):S127-39. PubMed ID: 15501361
    [No Abstract]   [Full Text] [Related]  

  • 18. Autonomic dysfunction in Parkinson's disease.
    Dubow JS
    Dis Mon; 2007 May; 53(5):265-74. PubMed ID: 17656188
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug Insight: new drugs in development for Parkinson's disease.
    Colosimo C; Fabbrini G; Berardelli A
    Nat Clin Pract Neurol; 2006 Nov; 2(11):600-10. PubMed ID: 17057747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug therapy for Parkinson's disease.
    Hermanowicz N
    Semin Neurol; 2007 Apr; 27(2):97-105. PubMed ID: 17390254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.